Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Downing

Showing results (441-450 of 537) with videos related to

Pageof 54
Sort By:
Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
Genome Research|December 11, 2012
Rare allelic forms of PRDM9 associated with childhood leukemogenesisJulie Hussin, Daniel Sinnett, Ferran Casals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Novel methylation biomarker panel for the early detection of pancreatic cancerJoo Mi Yi, Angela A Guzzetta, Vasudev J Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseKathryn G Roberts, Deqing Pei, Dario Campana, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
The American Journal of Surgical Pathology|January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapiesJeffrey S Ross, Kai Wang, Janna V Rand, et al.
Genome Biology|May 30, 2020
CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing dataLiqing Tian, Yongjin Li, Michael N Edmonson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE)Zhaoming Wang, Qi Liu, Carmen L Wilson, et al.
Blood|April 10, 2015
PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemiaJinjun Dang, Lei Wei, Jeroen de Ridder, et al.
Blood|February 9, 2010
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaRichard C Harvey, Charles G Mullighan, I-Ming Chen, et al.
Pageof 54

Showing results (441-450 of 537) with videos related to

Sort By:
Pageof 54
Blood|July 15, 2004
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research HospitalChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
Genome Research|December 11, 2012
Rare allelic forms of PRDM9 associated with childhood leukemogenesisJulie Hussin, Daniel Sinnett, Ferran Casals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Novel methylation biomarker panel for the early detection of pancreatic cancerJoo Mi Yi, Angela A Guzzetta, Vasudev J Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2014
Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseKathryn G Roberts, Deqing Pei, Dario Campana, et al.
Leukemia|August 26, 2016
Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapyC-H Pui, D Pei, S C Raimondi, et al.
The American Journal of Surgical Pathology|January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapiesJeffrey S Ross, Kai Wang, Janna V Rand, et al.
Genome Biology|May 30, 2020
CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing dataLiqing Tian, Yongjin Li, Michael N Edmonson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2018
Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE)Zhaoming Wang, Qi Liu, Carmen L Wilson, et al.
Blood|April 10, 2015
PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemiaJinjun Dang, Lei Wei, Jeroen de Ridder, et al.
Blood|February 9, 2010
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemiaRichard C Harvey, Charles G Mullighan, I-Ming Chen, et al.
Pageof 54